Is Scheduling Wizard profitable in 2026?

No revenue or profitability figures have been disclosed. Scheduling Wizard is a 3-person YC W26 startup as of 2026-07-21 with vendor-claimed traction across 20 departments and 16 hospitals but no independently verified revenue.

Could AI replace Scheduling Wizard's core product?

Yes, its risk is high. The core task, constrained scheduling optimization against ACGME duty-hour rules, is textbook AI-solvable, and incumbent QGenda (Hearst-owned) already ships an AI-driven Scheduler as of spring 2026, narrowing Scheduling Wizard's differentiation.

Who is Scheduling Wizard's biggest competitor?

QGenda, the Hearst-owned market leader in physician scheduling, is the named incumbent threat as of 2026, having shipped an AI-driven Scheduler and AI-Optimized Scheduling Engine. YC peer YouShift (launched 2025-02-26) is also racing the same academic scheduling niche.

Who owns Scheduling Wizard?

Scheduling Wizard is privately founder-owned, backed by Y Combinator (W26 batch). Co-founders are Zachary Dermody (COO, Johns Hopkins 2024) and Abdelrahman Hamimi (CTO, Johns Hopkins CS/Economics), per the company's YC profile dated 2026-03-11.

How big is Scheduling Wizard right now?

As of 2026-07-21, YC's directory lists Scheduling Wizard at 3 employees. The company vendor-claims service to 20 departments across 16 hospitals as of its 2026-03-11 YC launch, including marquee sites like Mass General and Johns Hopkins.

Has Scheduling Wizard raised any funding?

Unclear and disputed. One aggregator claims a $500K pre-seed round led by Y Combinator; another states the company has never raised funding. No primary press release or confirmed round exists as of mid-2026.

YC Winter 2026 · United States

Scheduling Wizard

Outsourced scheduling service that runs GME and attending calendars for teaching hospitals.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from Fall 2026 · Every call on the record Checkpoint: First academic-year renewal and expansion cycle across its 20 department contracts

The call

Scheduling Wizard holds a narrow foothold in academic hospital scheduling built on alumni trust, while QGenda's AI scheduler and Salesforce's VA deal show the underlying task attracting much larger players.

Scheduling Wizard sells scheduling services to academic medical centers, handling the messy work of assigning doctors to shifts and managing rules. Right now, the company has an edge because hospitals are sticky customers and switching services is annoying once you are locked in. But QGenda, a big health-care software company, already built an AI scheduler that does this job automatically, and Salesforce is pushing into hospital scheduling too. The real question is whether Scheduling Wizard can keep growing sales to new departments in the same hospitals or expand to fresh customers, because if that growth stops, there is no reason hospitals would not just switch to the AI version from a bigger company.

Why

AI pressure: QGenda AI-Driven Scheduler and AI-Optimized Scheduling Engine. Constrained-optimization scheduling is a solved AI problem; QGenda already ships an AI scheduler that could replace the manual layer Scheduling Wizard sells as a service. Could AI do the core job? Yes, likely.

Bigger players: Salesforce (via its $1.6B VA scheduling and care-coordination contract). Salesforce is proving platform-scale AI scheduling can work inside a huge public health system, a template that could move toward academic medical centers next. Could a giant copy it? Yes, easily.

What protects it. Warm alumni-network sales into Johns Hopkins-linked hospitals and hands-on management of messy institutional scheduling rules that off-the-shelf software doesn't yet absorb.

What would change this call

QGenda announces a managed-service scheduling tier within 12-18 months. Would show the incumbent closing Scheduling Wizard's core service gap.
YouShift signs a major academic medical center as a customer. Would show a direct YC peer capturing Scheduling Wizard's target niche.
Scheduling Wizard renews or expands departments outside the Johns Hopkins alumni network. Would show real workflow lock-in versus reliance on founder connections.

Key numbers

3-person team as of mid-2026 (2026-07-21)
20 departments across 16 hospitals served (2026-03-11)
Vendor claims 95%+ cut in manual scheduling time (2026-03-11)

Named risks

QGenda or AMiON could add a managed-service tier, eliminating Scheduling Wizard's outsourcing wedge within 18 months. Severity: high
Core scheduling task is constrained optimization on public ACGME rules, easily automatable by generic AI agents. Severity: high
Conflicting funding reports (500K pre-seed vs no funding raised) leave capital runway unclear. Severity: medium
Only 3 employees with no open job listings as of 2026-07-21 signals stalled hiring and growth. Severity: medium
Direct YC peer YouShift could land a major academic contract first, squeezing the wedge. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
QGenda	losing to	Hearst-owned QGenda already ships an AI-driven Scheduler as of spring 2026, closing Scheduling Wizard's wedge
YouShift	contesting	YC peer launched AI-powered shift scheduling for healthcare on 2025-02-26, racing the same academic niche
Salesforce	gaining on	Signed up to $1.6B VA AI scheduling deal, announced 2026-07-24, entering adjacent healthcare AI-scheduling turf
AMiON	contesting	Established on-call scheduling platform already entrenched in residency programs and academic medical centers

Questions people ask

Is Scheduling Wizard profitable in 2026?: No revenue or profitability figures have been disclosed. Scheduling Wizard is a 3-person YC W26 startup as of 2026-07-21 with vendor-claimed traction across 20 departments and 16 hospitals but no independently verified revenue.
Could AI replace Scheduling Wizard's core product?: Yes, its risk is high. The core task, constrained scheduling optimization against ACGME duty-hour rules, is textbook AI-solvable, and incumbent QGenda (Hearst-owned) already ships an AI-driven Scheduler as of spring 2026, narrowing Scheduling Wizard's differentiation.
Who is Scheduling Wizard's biggest competitor?: QGenda, the Hearst-owned market leader in physician scheduling, is the named incumbent threat as of 2026, having shipped an AI-driven Scheduler and AI-Optimized Scheduling Engine. YC peer YouShift (launched 2025-02-26) is also racing the same academic scheduling niche.
Who owns Scheduling Wizard?: Scheduling Wizard is privately founder-owned, backed by Y Combinator (W26 batch). Co-founders are Zachary Dermody (COO, Johns Hopkins 2024) and Abdelrahman Hamimi (CTO, Johns Hopkins CS/Economics), per the company's YC profile dated 2026-03-11.
How big is Scheduling Wizard right now?: As of 2026-07-21, YC's directory lists Scheduling Wizard at 3 employees. The company vendor-claims service to 20 departments across 16 hospitals as of its 2026-03-11 YC launch, including marquee sites like Mass General and Johns Hopkins.
Has Scheduling Wizard raised any funding?: Unclear and disputed. One aggregator claims a $500K pre-seed round led by Y Combinator; another states the company has never raised funding. No primary press release or confirmed round exists as of mid-2026.

Timeline

2026-07-27Salesforce reported signing up to $1.6B VA deal for AI-powered scheduling and care coordination
2026-07-21YC directory shows Scheduling Wizard at 3 employees with no open job listings
2026-05-25YC Healthcare IT listing snapshot reconfirms 3-person team size
2026-03-11Scheduling Wizard publicly launches on YC Launch platform
2026-03-09Rebel Fund analysis calls YC W26 batch unusually strong, a possible funding tailwind
2025-02-26YC peer YouShift launches AI-powered shift scheduling for healthcare

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

CellType OctaPulse The Token Company